These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling. Yadav MK; Singh A; Swati D Appl Biochem Biotechnol; 2014 Aug; 173(8):2174-88. PubMed ID: 24970047 [TBL] [Abstract][Full Text] [Related]
3. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery. Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005 [TBL] [Abstract][Full Text] [Related]
5. Structure Based Docking and Molecular Dynamic Studies of Plasmodial Cysteine Proteases against a South African Natural Compound and its Analogs. Musyoka TM; Kanzi AM; Lobb KA; Tastan Bishop Ö Sci Rep; 2016 Mar; 6():23690. PubMed ID: 27030511 [TBL] [Abstract][Full Text] [Related]
6. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach. Kesharwani RK; Singh DV; Misra K J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library. Shah F; Mukherjee P; Gut J; Legac J; Rosenthal PJ; Tekwani BL; Avery MA J Chem Inf Model; 2011 Apr; 51(4):852-64. PubMed ID: 21428453 [TBL] [Abstract][Full Text] [Related]
8. Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design. Musyoka TM; Njuguna JN; Tastan Bishop Ö Malar J; 2019 May; 18(1):159. PubMed ID: 31053072 [TBL] [Abstract][Full Text] [Related]
9. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures. Hernández-González JE; Salas-Sarduy E; Hernández Ramírez LF; Pascual MJ; Álvarez DE; Pabón A; Leite VBP; Pascutti PG; Valiente PA Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2911-2923. PubMed ID: 30253205 [TBL] [Abstract][Full Text] [Related]
10. Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study. Boateng RA; Tastan Bishop Ö; Musyoka TM Malar J; 2020 Nov; 19(1):442. PubMed ID: 33256744 [TBL] [Abstract][Full Text] [Related]
11. The impact of whole genome sequence data on drug discovery--a malaria case study. Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369 [TBL] [Abstract][Full Text] [Related]
12. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review. Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154 [TBL] [Abstract][Full Text] [Related]
13. South African Abietane Diterpenoids and Their Analogs as Potential Antimalarials: Novel Insights from Hybrid Computational Approaches. Musyoka T; Bishop ÖT Molecules; 2019 Nov; 24(22):. PubMed ID: 31703388 [TBL] [Abstract][Full Text] [Related]
14. Cyclic peptide engineered from phytocystatin inhibitory hairpin loop as an effective modulator of falcipains and potent antimalarial. Mishra M; Singh V; Tellis MB; Joshi RS; Pandey KC; Singh S J Biomol Struct Dyn; 2022 May; 40(8):3642-3654. PubMed ID: 33292080 [TBL] [Abstract][Full Text] [Related]
15. Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next? González JEH; Salas-Sarduy E; Alvarez LH; Valiente PA; Arni RK; Pascutti PG Curr Med Chem; 2024; 31(16):2234-2263. PubMed ID: 37711130 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. Desai PV; Patny A; Sabnis Y; Tekwani B; Gut J; Rosenthal P; Srivastava A; Avery M J Med Chem; 2004 Dec; 47(26):6609-15. PubMed ID: 15588096 [TBL] [Abstract][Full Text] [Related]
18. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory. Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575 [TBL] [Abstract][Full Text] [Related]
19. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets. Qidwai T Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of α-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum. Weldon DJ; Shah F; Chittiboyina AG; Sheri A; Chada RR; Gut J; Rosenthal PJ; Shivakumar D; Sherman W; Desai P; Jung JC; Avery MA Bioorg Med Chem Lett; 2014 Mar; 24(5):1274-9. PubMed ID: 24507921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]